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SUMMARY
Idiopathic progressive subglottic stenosis is a rare cause of tracheal narrowing. Partial cricotracheal resection and anastomosis can cure idi-
opathic stenosis, even if some patients may require multiple interventions and experience voice and swallowing deterioration. We investigated 
risk factors for retreatment and assessed the impact of crico-tracheal resection on functional parameters. We conducted a retrospective multi-
centric study on 44 female patients (mean age 52.6 ± 13.1 years) affected by idiopathic stenosis and treated by crico-tracheal resection between 
2002 and 2016. Functional outcomes after crico-tracheal resection were assessed by the airway-dyspnoea-voice-swallowing score (range 1-5, 
with “1” expressing normal and “5” completely altered function). Previous treatments, grade of stenosis, site, airway comorbidities, age and 
resection length were tested as predictors of postoperative complications and number of additional treatments, using bivariate and multivariate 
analysis.  The overall decannulation rate was 97.3%. The dyspnoea score improved (mean variation 1.4 ± 1.0; p < 0.001), while voice and swal-
lowing were negatively affected (mean variation 1.6 ± 0.9 and 0.5 ± 0.7, respectively; p < 0.001). Airway comorbidities were associated with a 
higher rate of complications (p < 0.05). Retreatments were more frequent in patients with postoperative complications (p < 0.05). The length of 
resection correlated with the number of subsequent treatments (R = 0.52; p < 0.01). At multivariate analysis, post-operative complications were 
predicted by comorbidities and disease stage (p < 0.05); number of retreatments was linked to the length of resection (p < 0.05) as well as with 
the application of mitomycin C (p < 0.001). Crico-tracheal resection for idiopathic progressive subglottic stenosis offers good functional results 
in terms of airway patency. These data suggest that a higher complication rate can be expected in patients affected by comorbidities. Moreover, 
more extensive surgical resection seems to be associated with the occurrence and number of subsequent retreatments. On the contrary, the local 
application of an anti-proliferative drug does not seem to be of use in preventing recurrences.
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RIASSUNTO 
La stenosi idiopatica subglottica progressiva rappresenta una rara causa di restringimento della laringe. La resezione parziale con succes-
siva anastomosi può potenzialmente essere curativa; nonostante ciò alcuni pazienti richiedono un numero elevato di ritrattamenti e possono 
sviluppare disfonia e disfagia in seguito all’intervento. In questo studio abbiamo investigato i fattori di rischio per il ritrattamento e abbiamo 
valutato l’impatto della resezione crico-tracheale sui parametri funzionali. È stata condotta un’analisi multicentrica retrospettiva su 44 pa-
zienti di sesso femminile (età media 52,6 ± 13,1 anni), sottoposti a resezione crico-tracheale tra il 2002 e il 2016. Gli esiti funzionali sono stati 
valutati utilizzando la scala “vie aeree-dispnea-voce-disfagia” dove ognuno di questi parametri è stato valutato con un punteggio da 1 a 5, 
ove 1 esprime una funzione normale e 5 una funzione completamente compromessa. L’esistenza di trattamenti pregressi, il grado di stenosi, il 
sito della stenosi, la presenza di comorbidità delle vie aeree, l’età e la lunghezza del segmento resecato sono stati testati all’analisi bivariata e 
multivariata come predittori di complicanze e di trattamenti aggiuntivi. Il trattamento ha permesso la decannulazione del paziente nel 97,3% 
dei casi. L’indice di dispnea è migliorato (variazione media 1,4 ± 1,0; p < 0,001), mentre quelli relativi alla voce e alla deglutizione sono 
peggiorati (variazione media 1,6 ± 0,9 and 0,5 ± 0,7, rispettivamente; p < 0,001). I pazienti affetti da comorbidità delle vie aeree hanno pre-
sentato un tasso più alto di complicanze (p < 0,05). La lunghezza del segmento resecato ha dimostrato una correlazione diretta con il numero 
dei ritrattamenti (R = 0,52; p < 0,01). All’analisi multivariata, le complicazioni post-operatorie erano predette dall’esistenza di comorbidità 
e dallo stadio di malattia (p < 0,05); il numero dei ritrattamenti era associato alla lunghezza del tratto resecato (p < 0,05) e all’applicazione 
di Mitomicina C (p < 0,001). La resezione crico-tracheale offre dei buoni risultati funzionali per la cura della stenosi idiopatica subglottica 
progressiva, in termini di pervietà delle vie aeree. I nostri dati suggeriscono che i pazienti affetti da comorbidità possono presentare un’inci-
denza più alta di complicazioni. Inoltre, resezioni chirurgiche più estese sembrano essere associate all’incidenza e al numero dei ritrattamenti. 
Al contrario, l’applicazione di sostanza anti-proliferativa non sembra essere utile nella prevenzione delle recidive.
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Introduction
Idiopathic progressive subglottic stenosis (IPSS) is a rare, 
acquired cause of upper airway related dyspnoea, whose 
pathologic hallmark is represented by progressive scar-
ring of the subglottic larynx and upper trachea. Even 
though its pathogenic mechanisms remain obscure, onset 
of IPSS has been linked with severe coughing, gastro-
oesophageal reflux disease (GERD) or to autoimmune 
inflammatory mechanisms. These mechanisms have been 
proposed as possible triggers of an inflammatory process 
that is later sustained by unclear mechanisms 1-4. Moreo-
ver, a distinctive hallmark of IPSS is represented by its al-
most exclusive predilection for peri-menopausal women, 
with a median age of 47 years 5. Respiratory distress usu-
ally has an insidious onset, but it eventually progresses 
from exertional dyspnoea to respiratory symptoms even at 
rest and stridor. The disease shows usually a slow but con-
stant progression and all patients eventually require surgi-
cal treatment to restore respiratory function and quality of 
life  4 6 7. Different surgical options have been advocated 
for IPSS management, ranging from endoscopic to open-
neck approaches  4 6-8. Recent studies seem to favour the 
latter, as laryngotracheal reconstruction techniques have 
shown better long-term results and lower recurrence rates 
compared with transoral surgery  6  9-13. In fact, patients 
treated by endoscopic balloon dilatation alone needed 
to be repeatedly treated to maintain functional airway 
patency  7; this leads to a negative impact on the overall 
quality of life, without attaining proper cure  14. Similar 
results have been observed by CO2 laser-assisted IPSS re-
section 15. Conversely, partial cricotracheal resection and 
anastomosis (PCTRA) can potentially achieve complete 
and permanent restoration of airway function 5.
However, a significant percentage of patients show multi-
ple relapses, even in case of apparent total resection of the 
affected segment 7 8. In light of this, we investigated the 
risk factors for post-operative complications and re-oper-
ation in IPSS treated by PCTRA as well as the impact of 
the procedure on functional parameters such as breathing, 
phonation and swallowing in a large multicentre series of 
subjects managed by a common therapeutic strategy.
Materials and methods
Patient population
We retrospectively analysed clinical data of 44 female 
patients (mean age 52.6 years; range 31-79) affected by 
IPSS and treated by PCTRA at the Department of Otorhi-
nolaryngology, Katharinenhospital, Stuttgart, Germany 
between July 2010 and June 2016 and in the Departments 
of Otorhinolaryngology Head and Neck Surgery, Univer-
sities of Brescia and Genoa, Italy between June 2002 and 
August 2014. The inclusion criteria were: no history of 
intubation at least 2 years before symptoms onset, no pre-
vious tracheotomy, no concurrent head and neck trauma, 
airway infection, or systemic autoimmune diseases. 
All patients signed a written informed consent form, 
which was reviewed and approved by the respective lo-
cal Ethics Committees and included the utilisation of an-
onymised patient data for research purposes.
Endoscopic work-up
The endoscopic evaluation included a detailed static and 
dynamic analysis of the airways 16. Pre-operative assess-
ment was performed under direct laryngoscopy, in spon-
taneous ventilation using 0° and 30° rigid telescopes (Karl 
Storz, Tuttlingen, Germany) to examine passive vocal fold 
mobility, as well as the precise stenosis site and its cranio-
caudal extension. Subsequently, adequate laryngeal expo-
sure in microlaryngoscopy was obtained with different la-
ryngoscopes such as the Sataloff (Microfrance® iXomed, 
Saint Aubin Le Monial, France), Dedo or Dedo-Ossoff 
(Pilling, Philadelphia, PA, USA) to precisely evaluate and 
measure the extension, consistency and grade of IPSS. A 
biopsy was always performed to rule out an autoimmune 
background of the disease process.
Operative technique
In all patients, PCTRA was performed as a single-stage 
surgical procedure aimed at treating stenosis of the sub-
glottic larynx and trachea by complete resection of the af-
fected airway segment, including the anterior cricoid arch, 
the mucosal layer of the cricoid plate potentially up to the 
cricoarytenoid joints and, when needed, the first tracheal 
ring(s) in order to reestablish its continuity in a single step 
by thyro-crico-tracheal anastomosis 17. At the end of the 
procedure, all patients were primarily extubated and then 
monitored at in an intensive care unit.
Functional outcomes, complications frequency and need 
for retreatment after PCTRA
Functional outcomes were assessed with the Airway-
Dyspnoea-Voice-Swallowing score (ADVS) 18. This scale 
consists of 4 functional domains, including airway (A), 
dyspnea (D), voice (V), and swallowing (S). All parts of 
the scoring system have a 1 to 5 ordinal progressive scale, 
with “1” expressing normal and “5” completely impaired 
function. This scoring was obtained before and after in-
tervention.
Variables including previous treatments, grade and locali-
sation of IPSS, airway comorbidities, age and resection 
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length were all tested as predictors of post-operative com-
plications and number of additional treatments needed to 
cure the patient.
Statistical analysis
A T-test for paired samples was used to compare pre- and 
post-operative ADVS scores between patients. Correlation of 
previous treatments, grade and localisation of IPSS, airway 
comorbidities, age and resection length with post-operative 
complications and number of additional treatments was 
tested by bivariate analysis using Pearson’s product-moment 
correlation coefficient index. Significant correlations 
were then inserted and tested using a multivariate model 
(MANOVA). A p value < 0.05 was considered statistically 
significant. The SPSS program (SPSS, v. 21.0, IBM, Armonk 
NY, USA) was used for statistical analysis.
Results
Clinical outcomes after PCTRA
The operation-specific decannulation rate following PCTRA 
was 97.3%, resulting in a permanent tracheostomy in one pa-
tient due to a major post-operative complication. However, 6 
subjects (13.6%) were submitted to post-operative temporary 
tracheotomy (mean duration 9.3 days; range 2-18), because 
of serious complications (2 oedema, 1 haematoma, 2 tracheal 
necrosis and 1 inversion of vocal fold motility), which arose 
5-17 days after the intervention (median = 11 days).
This, however, had no influence on the airway score 
(1.12 ± 0.5 before PCTRA vs 1.12 ± 0.5 after PCTRA, 
Fig.  1). The dyspnoea score improved significantly 
(2.89 ± 0.72 before PCTRA vs 1.45 ± 0.66 after PCTRA; 
p < 0.001, Fig. 1), as most of patients showed significant 
improvement in symptoms. In fact, no patient presented 
post-operative resting dyspnoea. 
On average, voice was negatively affected in all patients 
(1.34 ± 0.71 before PCTRA vs 2.91 ± 0.42 after PCTRA; 
p < 0.001, Fig. 1), as the majority of patients passed from 
slight or absent voice problems to post-operative dyspho-
nia due to cricothyroid muscles and cricoid arch resection 
with ensuing loss of vocal pitch modulation. As a result, 
most subjects experienced significant difficulties in being 
heard or understood in loud environments. 
Similarly, swallowing scores were negatively affected 
(1.11 ± 0.32 before PCTRA vs 1.57 ± 0.73 after PCTRA; 
p < 0.001, Fig. 1). After surgery, the majority of patients 
showed the onset of mild subjective swallowing difficul-
ties even though they were able to eat a normal diet, in 
comparison to intact swallowing prior to surgery. 
Post-operative complications
Notably, all patients affected by airway comorbidities (asth-
ma, chronic obstructive pulmonary disease, unilateral vocal 
Fig. 1. Pre- and post-operative ADVS scores. While airway scores were unaffected by the surgical procedure, subjective dyspnoea improved significantly. 
However, this came at the cost of a relative deterioration in voice and swallowing scores. 
*** = p < 0.001
pre-op.
post-op.
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fold palsy) encountered post-operative complications. By 
contrast, adverse events occurred in 52.6% of patients with-
out pre-existing airway conditions (p < 0.05 vs the remain-
ing patients). The most commonly observed post-operative 
complication was laryngeal oedema, affecting 12 (27.3%) 
patients, and resulting in short-term orotracheal intubation 
in 5 cases, endoscopic removal of fibrin tissue or injection 
of triamcinolone acetonide (Volon A, Dermapharm AG) 
in 5, endoscopic balloon dilatation in one and short-term 
tracheotomy in one. Three (6.8%) subjects experienced 
post-operative cervical emphysema followed by anasto-
motic revision in 2 cases and short-term orotracheal intu-
bation in one. Cervical haematoma occurred in 4 patients 
(9.1%), and required neck surgical re-exploration in 2. The 
most severe observed complication, in the form of tracheal 
necrosis, occurred in 4 (9.1%) patients, resulting in tem-
porary endoluminal tracheal stent in one case, temporary 
tracheotomy in 2 and permanent tracheotomy in another. 
Unilateral vocal cord paralysis occurred in 2 (4.5%) sub-
jects, and was managed by intracordal injection of Calcium 
Hydroxyapatite (Radiesse, Merz Aesthetics) in both cases. 
Temporary bilateral vocal fold paresis occurred in only one 
(2.3%) patient and was treated by a reversible endoscopic 
unilateral arytenoid lateropexy according to Lichtenberg-
er’s technique 19. See Figure 2 for details.
Additional treatments
Twenty-six (59.1%) patients required additional endo-
scopic treatments (mean 3.2 ± 2.3; range 1-9), but no fur-
ther open-surgical procedure. The endoscopic revisions 
included balloon dilatations (Inspira Air Technology, 
Acclarent) and topical injection of triamcinolone aceto-
nide in 9 cases, and balloon dilatation with topical ap-
plication of mitomycin C (2 mg/ml for 2 minutes) in 12 
cases. Granulation tissue was removed in 11 subjects. See 
Figure 3 for details. Retreatments were significantly more 
frequent in patients who presented post-operative com-
plications (2.2 ± 1.7 vs 3.7 ± 2.5; p < 0.05). Moreover, 
length of resection directly correlated with the number of 
subsequent treatments (R = 0.52; p < 0.01, Fig. 4). Topical 
application of mitomycin C did not improve the clinical 
outcome; on the contrary, patients receiving mitomycin C 
had to be re-treated more frequently compared with those 
who did not (4.1 ± 3 vs 1.1 ± 1.7; p < 0.001). This find-
ing was independent from clinical stage as well as from 
length of resected segments.
MANOVA
At multivariate analysis, onset of post-operative com-
plications was predicted by the presence of pre-opera-
tive comorbidities (RR 7.2; p < 0.05) as well by disease 
stage (RR  =  5.1, respectively; p  <  0.05). Conversely, 
Fig. 2. Post-operative complications. Most patients suffered from complications following crico-tracheal surgery. However, most of these complications were 
mild and reversible; only one patient suffered long-term damage.
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history of previous treatment did not influence the sur-
gery outcome.
Clinical stage at baseline and history of previous surgeries 
did not predict the need or the number of additional pro-
cedures. However, number of subsequent retreatment was 
predicted by the length of resected segment (RR = 2.4; 
p < 0.05).
Regarding functional outcomes, the length of the resected 
segment was strongly associated with the post-operative 
subjective dyspnoea score (p < 0.01). 
p < 0.001
R = 0.52
Fig. 3. Frequency of retreatments. None of the patients required re-intervention with open surgery. However, endoscopic treatments were necessary in about 
half of patients. Local application of anti-proliferative drugs produced no appreciable effect.
Fig. 4. Correlation between length of resection and number of re-interventions. Longer resections were associated to recidivating stenosis, perhaps implying 
that a more extensive resection is more likely to trigger further inflammatory reactions.
I. Fiz et al.
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Application of mitomycin C was directly and strongly as-
sociated with occurrence of retreatments (p < 0.001) as 
well as with the number of additional surgical procedures 
(p = 0.001). 
Discussion
The present research confirms that the success rate for PC-
TRA is extremely high, similar to previous series 5. How-
ever, it also highlights that successful decannulation can 
come through this technique at a cost. In fact, patients were 
relieved of dyspnoea, but their phonatory and swallowing 
function were negatively affected. Moreover, there was 
a significant percentage of patients in which the stenosis 
recurs. Actually, when compared to other stenosis aetiolo-
gies, IPSS patients have longer duration of symptoms and 
a tendency to require multiple treatments 20 21. In fact, idio-
pathic stenosis appears to be sustained by a chronic inflam-
matory syndrome, at least partially dependent on hormone 
receptor unbalance 20-22; in IPSS, surgery may thus alleviate 
the symptoms, but not fully remove the underlying cause.
Nonetheless, our data help to shed light on the reasons 
underlying the tendency to relapse. In fact, it appears that 
pre-operative presence of any type of airway comorbidi-
ties may set the stage for the insurgence of post-operative 
complications, which in turn could promote the tendency 
to relapse. A greater size of the removed segment can also 
increase the risk of recurrence, other than possibly af-
fecting negatively the chance of dyspnoea improvement. 
Even though fully eliminating the affected segment and 
maintaining a safe resection margin is the objective of the 
PCTRA procedure, the available data suggests that IPSS 
is an abnormal inflammatory reaction triggered by an un-
apparent stimulus 23-25. In this context, treatment with PC-
TRA may per se constitute a trigger, capable of inducing 
an inflammatory response in a previously unaffected (but 
otherwise susceptible) airway segment. In longer resec-
tions, force applied to the suture margins, as well as wider
and lengthier tissue manipulation could negatively impact
the repair process and constitute a stimulus for the above-
mentioned inflammatory reaction. This reasoning could 
also explain the inefficacy of the adjuvant local applica-
tion of mitomycin, in accordance with the recent litera-
ture 26. Actually, patients treated with this drug presented 
a worse outcome, which does not seem to be dependent 
on selection bias (as the mitomycin subgroup had neither 
a higher stage nor a greater prevalence of comorbidities), 
but could be rather linked to respiratory epithelium dam-
age following local mitomycin application as well as to 
impaired wound healing and fibrin accumulation 27.
Given these considerations, the occurrence of voice and 
swallowing deterioration, the longer post-operative recovery 
and the higher risk of complications linked with PTCRA, the 
surgeon may be tempted to favor an endoscopic treatment.
However, the best possibility for cure lies in the first sur-
gery, as the patient can expect better long-term results in 
terms of airway stability and patency. Moreover, patients 
operated by endoscopic procedures will have to face more 
treatments and generally worse long-term outcomes. How-
ever, patients with a relatively high risk of perioperative 
complications, active airway comorbidities and in whom 
deterioration of the phonatory and swallowing functions is 
not acceptable could receive greater benefits from an en-
doscopic approach, embracing PCTRA only after multiple 
failed transoral attempts or worsening of airway problems.
It is then of utmost importance to thoroughly counsel the 
patient about intra- and post-operative risks and compli-
cations, including the possibility of additional endoscopic 
treatments and/or revision procedures  5. Moreover, pa-
tients should be warned about the frequent alterations of 
voice, which are more likely to occur when an open pro-
cedure is employed. In fact, they should be reassured that 
they will have a functional voice, but some changes may 
be noticed in comparison with pre-operative function.
This study has some intrinsic limitations: it is a retro-
spective evaluation of patients treated at three different 
centres over a prolonged period of time. However, diag-
nostic work-up, treatment philosophy, surgical technique, 
instrumentation and follow-up policy were comparable. 
Moreover, follow-up time was variable, as some patients 
treated in the early 2000s stopped attending visits after a 
long remission period and, conversely, some patients were 
recruited at relatively recent times. Finally, evaluation 
of functional parameters was based on the self-reported 
symptoms’ heftiness. This evaluation was selected so as to 
avoid bias due to different calibration and availability of 
instrumentation in the three different centers. This could 
have caused difference in symptoms reporting; however, 
no statistically significant variations were detected among 
the scores in the three subgroups. 
Conclusions
Surgical treatment by PCTRA is effective in treating IPSS; 
however, life-long surveillance is necessary as the majority 
of patients will experience disease relapse during the course 
of follow-up. Accurate evaluation of the clinical history and 
careful assessment of airway related comorbidities are of 
great value in predicting, reducing, and properly managing 
perioperative complications, as well as the occurrence of 
relapse, in IPSS. The goals of PCTRA should be the res-
toration of airway physiologic patency, while reducing to 
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a minimum voice and swallowing-related sequelae and the 
complication rate. At present, this approach remains of spe-
cial relevance in management of IPSS and the one that al-
lows the highest rates of both short and long-term success.
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